By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – SomaLogic, which is developing molecular diagnostic tests based on aptamers, and NEC have signed an agreement to explore business opportunities in the life science and healthcare markets, the firms said today.

In addition, NEC has made an equity investment in SomaLogic, though the amount of the investment and other financial terms were not disclosed.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.